Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4848

1.

Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in hepatitis C virus (HCV) genotype 1a strains in the United Kingdom.

Beloukas A, King S, Childs K, Papadimitropoulos A, Hopkins M, Atkins M, Agarwal K, Nelson M, Geretti AM.

Clin Microbiol Infect. 2015 Jul 29. pii: S1198-743X(15)00734-X. doi: 10.1016/j.cmi.2015.07.017. [Epub ahead of print]

PMID:
26232533
2.

Hepatitis C virus infection and kidney transplantation: newer options and a brighter future ahead?

Del Bello D, Ross MJ, Huprikar SS.

Kidney Int. 2015 Aug;88(2):223-225. doi: 10.1038/ki.2015.180.

PMID:
26230200
3.

Treatment of Chronic HCV Genotype 1 Coinfection.

Boesecke C, Rockstroh JK.

Curr HIV/AIDS Rep. 2015 Jul 31. [Epub ahead of print]

PMID:
26228050
5.

Chronic Hepatitis C Virus Infection Is Associated with Subclinical Coronary Atherosclerosis in the Multicenter AIDS Cohort Study (MACS): a Cross-Sectional Study.

McKibben RA, Haberlen SA, Post WS, Brown TT, Budoff M, Witt MD, Kingsley LA, Palella FJ Jr, Thio CL, Seaberg EC.

J Infect Dis. 2015 Jul 27. pii: jiv396. [Epub ahead of print]

PMID:
26216904
6.

Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study.

Gordon SC, Lamerato LE, Rupp LB, Holmberg SD, Moorman AC, Spradling PR, Teshale E, Xu F, Boscarino JA, Vijayadeva V, Schmidt MA, Oja-Tebbe N, Lu M.

Am J Gastroenterol. 2015 Jul 28. doi: 10.1038/ajg.2015.203. [Epub ahead of print]

PMID:
26215529
7.

Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection.

Matthews L, Kleiner D, Chairez C, McManus M, Nettles MJ, Zemanick K, Morse C, Benator D, Kovacs J, Hadigan C.

AIDS Res Hum Retroviruses. 2015 Jul 27. [Epub ahead of print]

PMID:
26214341
8.

Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.

Pineda JA, Núñez-Torres R, Téllez F, Mancebo M, García F, Merchante N, Pérez-Pérez M, Neukam K, Macías J, Real LM; HEPAVIR Group of The Andalusian Society of Infectious Diseases (SAEI).

J Infect. 2015 Jul 23. pii: S0163-4453(15)00231-5. doi: 10.1016/j.jinf.2015.07.006. [Epub ahead of print]

PMID:
26212868
9.

Hepatitis B-related knowledge and vaccination in association with discrimination against hepatitis B in rural China.

Lijie Y, Wang J, Dawei Z, Anli L, Knut RW.

Hum Vaccin Immunother. 2015 Jul 25:0. [Epub ahead of print]

PMID:
26211570
10.

Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM.

Sherman AC, Sherman KE.

Curr HIV/AIDS Rep. 2015 Jul 25. [Epub ahead of print]

PMID:
26208812
11.

Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.

Mwatelah RS, Lwembe RM, Osman S, Ogutu BR, Aman R, Kitawi RC, Wangai LN, Oloo FA, Kokwaro GO, Ochieng W.

PLoS One. 2015 Jul 24;10(7):e0132287. doi: 10.1371/journal.pone.0132287. eCollection 2015.

12.

Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV).

Fujiwara E, Tomlinson SE, Purdon SE, Gill MJ, Power C.

J Clin Exp Neuropsychol. 2015 Jul 24:1-18. [Epub ahead of print]

PMID:
26207583
13.

A new era of therapy for hepatitis C virus infection.

Nyalakonda H, Utay NS.

Curr Opin Infect Dis. 2015 Jul 22. [Epub ahead of print]

PMID:
26203851
14.

Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy.

Loverro G, Di Naro E, Caringella AM, De Robertis AL, Loconsole D, Chironna M.

Sex Transm Infect. 2015 Jul 22. pii: sextrans-2014-051987. doi: 10.1136/sextrans-2014-051987. [Epub ahead of print]

PMID:
26203116
15.

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.

Wyles DL, Ruane PJ, Sulkowski MS, Dieterich D, Luetkemeyer A, Morgan TR, Sherman KE, Dretler R, Fishbein D, Gathe JC Jr, Henn S, Hinestrosa F, Huynh C, McDonald C, Mills A, Overton ET, Ramgopal M, Rashbaum B, Ray G, Scarsella A, Yozviak J, McPhee F, Liu Z, Hughes E, Yin PD, Noviello S, Ackerman P; ALLY-2 Investigators.

N Engl J Med. 2015 Jul 21. [Epub ahead of print]

16.

Infectious complications after liver transplantation in human immunodeficiency virus-infected recipients.

Teicher E, Boufassa F, Vittecoq D, Antonini TM, Tateo MG, Coilly A, Roque-Afonso AM, Kassis-Chikhani N, Lambotte O, Ichai P, Samuel D, Duclos-Vallee JC.

Transpl Infect Dis. 2015 Jul 20. doi: 10.1111/tid.12422. [Epub ahead of print]

PMID:
26192379
17.

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis.

Lamoury FM, Jacka B, Bartlett S, Bull RA, Wong A, Amin J, Schinkel J, Poon AF, Matthews GV, Grebely J, Dore GJ, Applegate TL.

PLoS One. 2015 Jul 20;10(7):e0131437. doi: 10.1371/journal.pone.0131437. eCollection 2015.

18.

HCV treatment: is it possible to cure all HCV patients?

Muir AJ, Naggie S.

Clin Gastroenterol Hepatol. 2015 Jul 17. pii: S1542-3565(15)00973-8. doi: 10.1016/j.cgh.2015.07.015. [Epub ahead of print] Review.

PMID:
26192145
19.

Prevalence of blood-borne viruses among Iranian dentists: Results of a national survey.

Ahmad Akhoundi MS, Momeni N, Norouzi M, Ghalichi L, Shamshiri AR, Alavian SM, Poortahmasebi V, Jazayeri SM.

Int J Occup Med Environ Health. 2015;28(3):593-602. doi: 10.13075/ijomeh.1896.00324.

20.

Liver transplantation for hepatitis C virus in the era of direct-acting antiviral agents.

Audrey C, Raffaele B.

Curr Opin HIV AIDS. 2015 Jul 17. [Epub ahead of print]

PMID:
26185921
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk